NGM Biopharmaceuticals logo

NGM Biopharmaceuticals

A biopharmaceutical company developing therapeutics for the treatment of cardio-metabolic and liver diseases

2

Funding Rounds

$74.6m

Money raised

Overview

A biopharmaceutical company developing therapeutics for the treatment of cardio-metabolic and liver diseases

Funding

Funding series

Funding Series Analysis

The company NGM Biopharmaceuticals has raised a total of $74.55m in funding over 2 rounds.

Key Insights:

  • NGM Biopharmaceuticals Series C round: $50m
  • NGM Biopharmaceuticals Series A round: $24.55m
NGM Biopharmaceuticals logo
NGM Biopharmaceuticals Series C round $50m
NGM Biopharmaceuticals logo
NGM Biopharmaceuticals Series A round $24.55m

Industries

NGM Biopharmaceuticals is active in the following industries:
  • Medical software
  • Biopharmaceutical
  • Engineering
  • Biomedical engineering
  • Enzyme kinetics
  • Technology
  • Biology
  • Biotechnology